AI News

    Marketers say NAD+ pills and infusions can boost longevity. What’s the evidence?

    Navigating the hype surrounding NAD+ supplementation and the lack of clinical evidence for human longevity.

    Read the full story at Google News AI
    GNA

    Google News AI

    Source

    Google News AI
    AI Analysis

    Generated insight by OnAirToday AI

    The trend toward longevity-focused biohacking highlights a growing gap between aggressive marketing claims and clinical proof. As interest in NAD+ grows, consumers remain vulnerable to unverified health promises that currently lack robust long-term human data.

    Powered by AI • Not a substitute for human analysisMore Insights →
    Read the full story at Google News AI →
    Share
    Filed under:AI News

    Comments

    Keep comments relevant and respectful. No links, advertising, self-promotion, or spam.

    0/1000